1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Merika E, Saif MW, Katz A, Syrigos K and
Morse M: Review. Colon cancer vaccines: An update. In vivo.
24:607–628. 2010.PubMed/NCBI
|
3
|
Lee DH, Keum N and Giovannucci EL:
Colorectal cancer epidemiology in the nurses' health study. Am J
Public Health. 106:1599–1607. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut pii:
gutjnl-2015-310912. 2016.(Epub ahead of print).
|
5
|
Stein A, Atanackovic D and Bokemeyer C:
Current standards and new trends in the primary treatment of
colorectal cancer. Eur J Cancer. 47:(Suppl 3). S312–S314. 2011.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Desch CE, Benson AB III, Somerfield MR,
Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS
and Petrelli NJ: American Society of Clinical Oncology: Colorectal
cancer surveillance: 2005 update of an American society of clinical
oncology practice guideline. J Clin Oncol. 23:8512–8519. 2005.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Engstrom PF, Arnoletti JP, Benson AB III,
Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS,
Enzinger PC, et al: NCCN clinical practice guidelines in oncology:
Colon cancer. J Natl Compr Canc Netw. 7:778–831. 2009.PubMed/NCBI
|
9
|
Jeffery M, Hickey BE and Hider PN:
Follow-up strategies for patients treated for non-metastatic
colorectal cancer. Cochrane Database Syst Rev. CD002200:2007.
View Article : Google Scholar
|
10
|
Tjandra JJ and Chan MK: Follow-up after
curative resection of colorectal cancer: A meta-analysis. Dis Colon
Rectum. 50:1783–1799. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Figueredo A, Rumble RB, Maroun J, Earle
CC, Cummings B, McLeod R, Zuraw L and Zwaal C: Gastrointestinal
Cancer Disease Site Group of Cancer Care Ontario's Program in
Evidence-based Care: Follow-up of patients with curatively resected
colorectal cancer: A practice guideline. BMC Cancer. 3:262003.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Longo WE, Virgo KS, Johnson FE, Oprian CA,
Vernava AM, Wade TP, Phelan MA, Henderson WG, Daley J and Khuri SF:
Risk factors for morbidity and mortality after colectomy for colon
cancer. Dis Colon Rectum. 43:83–91. 2000. View Article : Google Scholar : PubMed/NCBI
|
13
|
Debarros M and Steele SR: Perioperative
protocols in colorectal surgery. Clinics Colon Rrectal Surg.
26:139–145. 2013. View Article : Google Scholar
|
14
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Nasif WA, Lotfy M, El-Sayed IH, El-Kenawy
Ael M, El-Shahat M and El-Hak NG: Implications of CEA and p53
overexpression in the poor prognosis of colorectal cancer. Med
Oncol. 23:237–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Morner ME, Gunnarsson U, Jestin P and
Svanfeldt M: The importance of blood loss during colon cancer
surgery for long-term survival: An epidemiological study based on a
population based register. Ann Surg. 255:1126–1128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Chang GJ, Rodriguez-Bigas MA, Skibber JM
and Moyer VA: Lymph node evaluation and survival after curative
resection of colon cancer: Systematic review. J Natl Cancer Inst.
99:433–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gunderson LL, Jessup JM, Sargent DJ,
Greene FL and Stewart AK: Revised TN categorization for colon
cancer based on national survival outcomes data. J Clin Oncol.
28:264–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Parnaby CN, Scott NW, Ramsay G, MacKay C,
Samuel L, Murray GI and Loudon MA: Prognostic value of lymph node
ratio and extramural vascular invasion on survival for patients
undergoing curative colon cancer resection. Br J Cancer.
113:212–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
García-Solano J, Conesa-Zamora P,
Trujillo-Santos J, Mäkinen MJ and Pérez-Guillermo M: Tumour budding
and other prognostic pathological features at invasive margins in
serrated colorectal adenocarcinoma: A comparative study with
conventional carcinoma. Histopathology. 59:1046–1056. 2011.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Saha AK, Smith KJ, Sue-Ling H, Sagar PM,
Burke D and Finan PJ: Prognostic factors for survival after
curative resection of Dukes' B colonic cancer. Colorectal Dis.
13:1390–1394. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bouzourene H, Gervaz P, Cerottini JP,
Benhattar J, Chaubert P, Saraga E, Pampallona S, Bosman FT and
Givel JC: p53 and Ki-ras as prognostic factors for Dukes' stage B
colorectal cancer. Eur J Cancer. 36:1008–1015. 2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Allegra CJ, Paik S, Colangelo LH, Parr AL,
Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N and Wieand HS:
Prognostic value of thymidylate synthase, Ki-67, and p53 in
patients with Dukes' B and C colon cancer: A national cancer
institute-national surgical adjuvant breast and bowel project
collaborative study. J Clin Oncol. 21:241–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lane DP: Cancer. p53, guardian of the
genome. Nature. 358:15–16. 1992. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Perrone G, Vincenzi B, Santini D, Verzì A,
Tonini G, Vetrani A and Rabitti C: Correlation of p53 and bcl-2
expression with vascular endothelial growth factor (VEGF),
microvessel density (MVD) and clinico-pathological features in
colon cancer. Cancer Lett. 208:227–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye
S, Ling S, Jiang L, Tian Y and Lin TY: Circulating miR-221 directly
amplified from plasma is a potential diagnostic and prognostic
marker of colorectal cancer and is correlated with p53 expression.
J Gastroenterol Hepatol. 25:1674–1680. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
El-Serafi MM, Bahnassy AA, Ali NM, Eid SM,
Kamel MM, Abdel-Hamid NA and Zekri AR: The prognostic value of
c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian
patients with stage II colorectal cancer. Cancer. 116:4954–4964.
2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liang JT, Huang KC, Jeng YM, Lee PH, Lai
HS and Hsu HC: Microvessel density, cyclo-oxygenase 2 expression,
K-ras mutation and p53 overexpression in colonic cancer. Br J Surg.
91:355–361. 2004. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Resnick MB, Routhier J, Konkin T, Sabo E
and Pricolo VE: Epidermal growth factor receptor, c-MET,
beta-catenin, and p53 expression as prognostic indicators in stage
II colon cancer: A tissue microarray study. Clin Cancer Res.
10:3069–3075. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Nasif WA, El-Emshaty HM, Tabll A, Elmasry
SA, Attallah AM and Elhak Gad NA: Immunoreactivity evaluation of
mutant p53 gene product with DNA ploidy pattern in colorectal
carcinoma. Hepatogastroenterology. 51:1001–1006. 2004.PubMed/NCBI
|
31
|
Sarasqueta AF, Forte G, Corver WE, de
Miranda NF, Ruano D, van Eijk R, Oosting J, Tollenaar RA, van Wezel
T and Morreau H: Integral analysis of p53 and its value as
prognostic factor in sporadic colon cancer. BMC Cancer. 13:2772013.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Allegra CJ, Parr AL, Wold LE, Mahoney MR,
Sargent DJ, Johnston P, Klein P, Behan K, O'Connell MJ, Levitt R,
et al: Investigation of the prognostic and predictive value of
thymidylate synthase, p53, and Ki-67 in patients with locally
advanced colon cancer. J Clin Oncol. 20:1735–1743. 2002. View Article : Google Scholar : PubMed/NCBI
|
33
|
Li M and Gu J: Changing patterns of
colorectal cancer in China over a period of 20 years. World J
Gastroenterol. 11:4685–4688. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Dilmeç F, Özgönül A, Akkafa F, Uzunkoy A
and Kuilenburg ABPV: Determination of ApaI and TaqI Polymorphisms
of VDR gene in a group of Turkish patients with colorectal cancer.
Hernia. 19:21258–21263. 2009.
|
35
|
Watanabe T, Wu TT, Catalano PJ, Ueki T,
Satriano R, Haller DG, Benson AB III and Hamilton SR: Molecular
predictors of survival after adjuvant chemotherapy for colon
cancer. N Engl J Med. 344:1196–1206. 2001. View Article : Google Scholar : PubMed/NCBI
|
36
|
Paluszkiewicz P, Berbec H,
Pawlowska-Wakowicz B, Cybulski M and Paszkowska A: p53 protein
accumulation in colorectal cancer tissue has prognostic value only
in left-sided colon tumours. Cancer Detect Prev. 28:252–259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS,
Charytonowicz E, Guillem JG, Cordon-Cardo C and Cohen AM: p53
nuclear overexpression: An independent predictor of survival in
lymph node-positive colorectal cancer patients. J Clin Oncol.
12:2043–2050. 1994. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lan YT, Chang SC, Li AF, Lin TC, Chen WS,
Jiang JK, Yang SH, Wang HS and Lin JK: p53 protein accumulation as
a prognostic marker in sporadic colorectal cancer. Int J Colorectal
Dis. 22:499–506. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Veruttipong D, Soliman AS, Gilbert SF,
Blachley TS, Hablas A, Ramadan M, Rozek LS and Seifeldin IA: Age
distribution, polyps and rectal cancer in the Egyptian
population-based cancer registry. World J Gastroenterol.
18:3997–4003. 2012. View Article : Google Scholar : PubMed/NCBI
|
40
|
Fang YJ, Wu XJ, Zhao Q, Li LR, Lu ZH, Ding
PR, Zhang RX, Kong LH, Wang FL, Lin JZ, et al: Hospital-based
colorectal cancer survival trend of different tumor locations from
1960s to 2000s. PLoS One. 8:e735282013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Elferink MA, de Jong KP, Klaase JM,
Siemerink EJ and de Wilt JH: Metachronous metastases from
colorectal cancer: A population-based study in North-East
Netherlands. Int J Colorectal Dis. 30:205–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Deliu IC, Georgescu EF and Bezna MC:
Analysis of prognostic factors in colorectal carcinoma. Rev Med
Chir Soc Med Nat Iasi. 118:808–816. 2014.PubMed/NCBI
|
43
|
Okuno K: Surgical treatment for digestive
cancer. Current issues- colon cancer. Dig Surg. 24:108–114. 2007.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Inoue M, Ohta M, Iuchi K, Matsumura A,
Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S,
et al: Benefits of surgery for patients with pulmonary metastases
from colorectal carcinoma. Ann Thorac Surg. 78:238–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Inoue M, Ohta M, Iuchi K, Matsumura A,
Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S,
et al: Benefits of surgery for patients with pulmonary metastases
from colorectal carcinoma. Ann Thorac Surg. 78:238–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Kobayashi H, West NP, Takahashi K,
Perrakis A, Weber K, Hohenberger W, Quirke P and Sugihara K:
Quality of surgery for stage III colon cancer: Comparison between
England, Germany, and Japan. Ann Surg Oncol. 21:(Suppl 3).
S398–S404. 2014. View Article : Google Scholar : PubMed/NCBI
|
47
|
Ahmadi O, Stringer MD, Black MA and McCall
JL: Influence of age and site of disease on lymph node yield in
colorectal cancer. N Z Med J. 127:31–40. 2014.PubMed/NCBI
|
48
|
Ueda Y, Yasuda K, Inomata M, Shiraishi N,
Yokoyama S and Kitano S: Biological predictors of survival in stage
II colorectal cancer. Mol Clin Oncol. 1:643–648. 2013.PubMed/NCBI
|
49
|
Galizia G, Ferraraccio F, Lieto E,
Orditura M, Castellano P, Imperatore V, Romano C, Vollaro M,
Agostini B, Pignatelli C and De Vita F: Prognostic value of p27,
p53, and vascular endothelial growth factor in Dukes A and B colon
cancer patients undergoing potentially curative surgery. Dis Colon
Rectum. 47:1904–1914. 2004. View Article : Google Scholar : PubMed/NCBI
|